Home › Breast Cancer › NCT00991094

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Data Collection to Assess Acute and Late Normal Tissue Sequelae in Proton Therapy for Adults

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol
* Patients must sign a study-specific consent form prior to study entry

Exclusion Criteria:

* Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site

About the study

This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.

What is being tested

• Quality-of-Life Assessment (other)
• Questionnaire Administration (other)

Sponsor: M.D. Anderson Cancer Center · Participants: 5,000 · Started: May 27, 2005

Contact the study team

• Steven J. Frank · Phone: 713-563-2300

Official record on ClinicalTrials.gov — NCT00991094

Locations in the U.S.

Conditions

• Breast Cancer
• Esophageal Cancer
• Blood Cancers
• Lung Cancer
• Brain and Spinal Cord Tumors
• Gastrointestinal Cancers

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.